Catabasis Pharmaceuticals, Inc. CATB

, $TANH , offering was at 1,65$ buy under 1,25$ , PT 1,65$ -2$

$BVXV about to break out reversal coming plus PR at 10 potential of 300-800% gain this week. Hope on before too late!!!

$MEDS News! Float 3m, Earnings report - Beats revenue double! Recently partnered with SingleCare, prescription saving services that provide prescription COVID drug discount, one of recently IPO, GoodRx s competitors, shares +24.68%, closed at 7.71 $WWR $ISIG $JMIA $LLIT $GRIL $SPY $GNUS $MARK $CIT $SPY $BAC $SPAQ $CODX

Explain the drop? Someone explain the PT? I held as long as I could but today I had to know when to fold em.

$OBSV Analysts expect $16-$36 per share.

Shareholders will be ecstatic, with their stake up 30% over the past week following ObsEva SA‘s (NASDAQ:OBSV) latest quarterly results. Revenues came in 113% better than analyst models expected, at US$4.0kwhile statutory losses per share were US$0.48, in line with forecasts. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.